CV Sciences Triples CBD Sales in Q2 to $12 .3 Million | CashCropToday
0 Shares 437 Views

CV Sciences Triples CBD Sales in Q2 to $12 .3 Million

July 25, 2018
437 Views

CV Sciences, Inc. (OTCQB: CVSI) announced this morning that the company’s second quarter 2018 revenue is expected to have reached $12.3 million, which is up 203% compared to their second quarter last year. The company owns the well-known hemp derived CBD product brand +CBD oil.

CV Sciences owns their own pharmaceutical drug division that works specifically on the research and development of commercial CBD Products. Their subsidiary +CBD Oil focused on the manufacturing, marketing, and distribution of Cannabidiol based products such as soft gel capsules, powdered capsules,  sublingual tinctures, topical and sprays.

In the announcement, CV Sciences indicated that the company has increased their retail store count to 1,968 organic health food stores as of the end of June 2018. By allowing customers to purchase online, as well as, through retail outlets across the country the company has been able to significantly increase its visibility with consumers.

CV Sciences, Inc. currently has a market cap of $234.82m and is trading at 2.769 per share.

You may be interested

Featured CCT Interview with CEO of Eden Labs AC Braddock
Manufacturing
21 views
Manufacturing
21 views

Featured CCT Interview with CEO of Eden Labs AC Braddock

Editor - August 20, 2018

Eden Labs LLC. has been developing and providing plant based extraction equipment out of Seattle, Washington for some of the largest and most respected companies involved in…

VividGro, a Pegasus Capital Advisors Portfolio Company,  Announces Partnership with Merida Capital Partners
Market Watch
241 views
Market Watch
241 views

VividGro, a Pegasus Capital Advisors Portfolio Company, Announces Partnership with Merida Capital Partners

Editor - August 17, 2018

Partnership to Focus on Growth in Horticultural and Cannabis Industries VividGro, LLC, a portfolio company of private equity firm Pegasus Capital Advisors (Pegasus), today announced it has…

Harborside to Go Public Via Canadian Reverse Takeover in Deal Valued at C$200 Million
Market Watch
333 views
Market Watch
333 views

Harborside to Go Public Via Canadian Reverse Takeover in Deal Valued at C$200 Million

Editor - August 15, 2018

Harborside, a California based cannabis dispensary brand with multiple locations, is planning the reverse takeover of Canadian public company Lineage Grow Company Ltd. (CSE: BUDD). Lineage is…

Leave a Comment

Your email address will not be published.

Most from this category

%d bloggers like this: